Skip to main content
Ovoca Bio Plc logo

Ovoca Bio Plc — Investor Relations & Filings

Ticker · OVXA ISIN · IE00B4XVDC01 LEI · 213800ST2AK5XQ1O5207 IR Manufacturing
Open in API
Filings indexed 99 across all filing types
Latest filing 2026-02-05 Regulatory Filings
Country IE Ireland
Listing IR OVXA

About Ovoca Bio Plc

https://ovocabio.com/

Ovoca Bio is a clinical-stage biopharmaceutical company focused on developing novel treatments for women's health. Its lead product candidate is Orenetide, a treatment for premenopausal women with hypoactive sexual desire disorder (HSDD), a condition characterized by a distressing lack of sexual desire and representing a significant area of high unmet medical need. The company is advancing Orenetide through clinical development for major global markets and has filed for marketing approval in the US and Europe. Ovoca Bio's strategy includes leveraging its patent portfolio and considering licensing or collaboration opportunities to accelerate the availability of its product candidates to patients.

Recent filings

Filing Released Lang Actions
Change of Name
Regulatory Filings Classification · 98% confidence The document is a short regulatory announcement (RNS) regarding a company name change and a change in the ticker symbol (TIDM). It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a general regulatory announcement regarding corporate identity, it falls under the RNS category.
2026-02-05 English
First Day of Dealings on AIM
Regulatory Filings Classification · 98% confidence The document is a regulatory announcement (RNS) from Ovoca Bio plc regarding the completion of a reverse takeover of Tadeen International Limited and the subsequent admission of its enlarged share capital to trading on the London Stock Exchange's AIM. It details the fundraising, the change of company name to Talisman Metals PLC, and provides information on the new project portfolio. While it mentions an 'Admission Document', the document itself is the announcement of the transaction completion and admission, not the Admission Document itself. Therefore, it is classified as a regulatory filing (RNS) as it serves as a formal corporate announcement of a material event.
2026-01-28 English
Result of Meeting
Regulatory Filings Classification · 98% confidence The document is an official announcement from Ovoca Bio plc regarding the results of a General Meeting and an Annual General Meeting (AGM). It explicitly states that all resolutions were passed at both meetings. While it mentions share capital reorganization and share issues, the primary purpose of the document is to declare the voting results of these meetings. Therefore, it falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-01-27 English
Notice of AGM
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 3,000 characters) from Ovoca Bio PLC stating that the 'Notice of Annual General Meeting' has been published and is being distributed to shareholders. It provides the date, time, and location of the upcoming AGM but does not contain the full meeting materials themselves. Following the 'Menu vs Meal' rule, this is an announcement of a report/document publication rather than the document itself, making it a Report Publication Announcement (RPA).
2025-12-31 English
Publication of Admission Document
Regulatory Filings Classification · 98% confidence The document is a regulatory announcement (RNS) from Ovoca Bio PLC regarding a proposed reverse takeover (acquisition of Tadeen International Limited), a change of company name, a fundraising, and the publication of an Admission Document. While it discusses significant corporate events, it functions as an announcement of the publication of the Admission Document and the Notice of EGM, rather than being the Admission Document itself. Per the 'Menu vs Meal' rule, announcements that state a report has been published or is available on the website are classified as Report Publication Announcements (RPA).
2025-12-31 English
Change of Broker
Regulatory Filings Classification · 100% confidence The document is a short announcement regarding a change in the company's broker (appointment of CMC Markets UK Plc). It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a general regulatory announcement issued via RNS (Regulatory News Service) that does not fall into a more specific category, it is classified as a Regulatory Filing.
2025-11-13 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.